Form 4: GE HealthCare Executive Acquires Shares and Stock Options

Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., reports acquisition of common stock and stock options.

Summary

• On March 1, 2024, Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., acquired 4,718 shares of common stock and 13,420 employee stock options.
• The common stock was acquired through an award of restricted stock units.
• 33% of the restricted stock units will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions.
• Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement.
• The employee stock options have an exercise price of $92.72.
• 33% of the employee stock options will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions.
• The employee stock options expire on March 1, 2034.
• Following the reported transactions, Stacherski beneficially owns 57,549 shares of GE HealthCare common stock and 13,420 derivative securities.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting transactions. The sentiment is slightly positive as insider ownership is generally viewed favorably, but it's a routine filing.

Positives

• The acquisition of shares and stock options by a high-ranking officer could be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the restricted stock units and the exercisability of the stock options are tied to continued service and other conditions, suggesting a long-term commitment from the executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Comparison to Industry Standards

• Stock option grants and restricted stock units are common forms of executive compensation in the healthcare technology industry.
• Vesting schedules are typically structured to incentivize long-term performance and retention, often over a 3-4 year period, which aligns with the vesting schedule outlined in the document.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment, as they indicate confidence from a key executive.

Key Dates